Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / pharmacology
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Azacitidine* / pharmacology
• Azacitidine* / therapeutic use
• Humans
• Leukemia, Myeloid, Acute* / drug therapy
• Leukemia, Myeloid, Acute* / genetics
• Leukemia, Myeloid, Acute* / pathology
• Mutation*
• Myelodysplastic Syndromes* / drug therapy
• Myelodysplastic Syndromes* / genetics
• Myelodysplastic Syndromes* / pathology
• Niclosamide* / pharmacology
• Niclosamide* / therapeutic use
• Tumor Suppressor Protein p53* / genetics